|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Interest-bearing time deposits | ||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||
| Interest-earning time deposits | ||||||||||||||||||
| Investments in available-for-sale securities at fair value | ||||||||||||||||||
| Investments in held-to-maturity securities, at amortized cost (fair values of $63,355 at March 31, 2025 and $67,505 at December 31, 2024) | ||||||||||||||||||
| Loans, net of allowance for credit losses of $8,670 at March 31, 2024 (unaudited) and $8,591 at December 31, 2023 | ||||||||||||||||||
| Investments in available-for-sale securities, at fair value | ||||||||||||||||||
| Investments in held-to-maturity securities, at cost (fair values of $46,837 as of June 30, 2026, and $52,326 at December 31, 2025) | ||||||||||||||||||
| Loans held-for-sale | ||||||||||||||||||
| Loans, net of allowance for credit losses of $8,808 at March 31, 2025 and $8,884 at December 31, 2024 | ||||||||||||||||||
| Loans, net of allowance for credit losses of $10,238 at June 30, 2026, and $10,255 at December 31, 2025. | ||||||||||||||||||
| Federal Home Loan Bank stock, at cost | ||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||
| Noninterest-bearing | ||||||||||||||||||
| Interest-bearing | ||||||||||||||||||
| Total deposits | ||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||
| Other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Shareholders' equity: | ||||||||||||||||||
| Preferred Stock, par value $0.01; Authorized: 1,000,000 shares; No shares issued | ||||||||||||||||||
| Common Stock, par value $0.01; Authorized: 30,000,000 shares; Issued and outstanding: 8,747,150 shares and 8,792,719 shares at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||
| Unallocated common shares held by the Employee Stock Ownership Plan | ||||||||||||||||||
| Total shareholders' equity | ||||||||||||||||||
| Total liabilities and shareholders' equity | ||||||||||||||||||
Loading...
